SLXN: Silexion Therapeutics Corp insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-09-28 | 13D stake cut | Moringa Sponsor, LP | 17.70% | -7.30 pts | SEC |
| 2026-08-19 | 13D amendment | Moringa Sponsor, LP | 25.00% | SEC | |
| 2026-08-18 | New 13G stake | Mitchell P. Kopin | 4.99% | +4.99 pts | SEC |
| 2026-08-13 | Fell below 5% | Mitchell P. Kopin | 0.00% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.